This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

PCT & hormone control

Aromasin (Exemestane)

The steroidal, irreversible aromatase inhibitor - no estrogen rebound after stopping.

1 min read 1 sources Titration Updated June 2026
Class
Aromatase inhibitor (steroidal, irreversible)
Use
Oral, every other day to daily
Half-life
about 24 hours
Status
Clinically approved (breast cancer)

Getting started

Typical dosing (research context)

Per-week figures in mg. Titrate by blood value. Steroidal, irreversible AI.

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What is Exemestane?

Exemestane (brand name Aromasin) is a steroidal, irreversible aromatase inhibitor - a so-called suicide inhibitor. Unlike reversible anastrozole, exemestane binds aromatase permanently and shuts the enzyme molecule down completely. The body has to make new aromatase to restore activity.

This information is for research and educational purposes only. No medical advice.

How it works

As a suicide inhibitor, exemestane binds aromatase irreversibly and deactivates it for good. That has a practical advantage: after stopping there is no estrogen rebound (no sudden estradiol spike) as can occur with reversible AIs. Exemestane also has a mildly androgenic structure itself and tends to affect lipids more favorably than non-steroidal AIs.

Exemestane vs anastrozole

  • Exemestane (steroidal, irreversible): no rebound after stopping, tends to be more lipid-friendly.
  • Anastrozole (non-steroidal, reversible): finer control in small steps, larger experience base in AAS research.

Dosing

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What the research shows

The Intergroup Exemestane Study (Coombes et al., NEJM 2004) showed that switching to exemestane after 2-3 years of tamoxifen improved disease-free survival in postmenopausal breast cancer. That confirms the strong and reliable estrogen lowering.

Side effects

  • Too-low estradiol: joint pain, libido loss, fatigue.
  • Watch bone density with long-term use.
  • Tends to be more lipid-friendly than non-steroidal AIs.

Storage

Store dry and protected from light. Out of reach of children.

Evidence

Sources

  1. 1 Exemestane after 2-3 years of tamoxifen in postmenopausal breast cancer (Intergroup Exemestane Study). Coombes et al., NEJM, 2004

Keep reading

More in the lexicon

In the shop

Aromasin (Exemestane) in the catalog

Sizes, prices and availability for research use. Straight from the lexicon to the product page.

View in shop